Showing results (341-350 of 9,918) with videos related to

Sort By:
Pageof 992
Bone Marrow Transplantation|January 1, 1992
Clinical application of intrauterine bone marrow transplantation for treatment of genetic diseases--feasibility studiesS Slavin, E Naparstek, M Ziegler, et al.
Bone Marrow Transplantation|January 1, 1992
The bare lymphocyte syndromeJ L Touraine, G L Marseglia, H Betuel, et al.
Bone Marrow Transplantation|January 1, 1992
Characterization of lymphocyte subpopulations in cord bloodC Rabian-Herzog, S Lesage, E Gluckman
Bone Marrow Transplantation|March 23, 2004
High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantationV Hazar, S Kansoy, A Küpesiz, et al.
Bone Marrow Transplantation|March 23, 2004
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipientsC Cordonnier, S Maury, C Pautas, et al.
Bone Marrow Transplantation|July 20, 2004
Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantationF Ferrara, S Palmieri, M Annunziata, et al.
Bone Marrow Transplantation|August 3, 2004
Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trialM P Devetten, M H Qazilbash, C L Beall, et al.
Bone Marrow Transplantation|May 25, 2004
Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantationK Thursky, G Byrnes, A Grigg, et al.
Bone Marrow Transplantation|May 11, 2004
Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onsetS K Sohn, D H Kim, J G Kim, et al.
Bone Marrow Transplantation|May 11, 2004
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapyS Kumar, M Q Lacy, A Dispenzieri, et al.
Pageof 992